These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. Strahlman ER, Vogel R, Tipping R, Clineschmidt CM. Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800 [Abstract] [Full Text] [Related]
6. Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group. Bron AM, Garcher CP, Sirbat D, Allaire CM, Lablache-Combier MJ, Trinquand CJ. Eur J Ophthalmol; 1997 Aug; 7(4):351-6. PubMed ID: 9457458 [Abstract] [Full Text] [Related]
11. Levobunolol vs timolol for open-angle glaucoma and ocular hypertension. Cinotti A, Cinotti D, Grant W, Jacobs I, Galin M, Silverstone D, Shin D, Esters J, Lee J, Bouchey R. Am J Ophthalmol; 1985 Jan 15; 99(1):11-7. PubMed ID: 3881032 [Abstract] [Full Text] [Related]
20. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group. Nordmann JP, Söderström M, Rouland JF, Malecaze F. Br J Ophthalmol; 2000 Feb 15; 84(2):181-5. PubMed ID: 10655195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]